{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:43:33Z","timestamp":1790516613693,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T00:00:00Z","timestamp":1494979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s10585-017-9849-7","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T08:13:29Z","timestamp":1495008809000},"page":"309-314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC)"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5719-4916","authenticated-orcid":false,"given":"Martin","family":"Graversen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6nke","family":"Detlefsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Kroll","family":"Bjerregaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Bau","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,17]]},"reference":[{"key":"9849_CR1","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374\u20131403","journal-title":"Eur J Cancer"},{"issue":"Suppl 1","key":"9849_CR2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/0284186X.2015.1114675","volume":"55","author":"JK Bjerregaard","year":"2016","unstructured":"Bjerregaard JK, Mortensen MB, Pfeiffer P (2016) Trends in cancer of the liver, gall bladder, bile duct, and pancreas in elderly in Denmark, 1980\u20132012. Acta Oncol 55(Suppl 1):40\u201345","journal-title":"Acta Oncol"},{"key":"9849_CR3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejso.2015.11.003","volume":"42","author":"VH Coupland","year":"2016","unstructured":"Coupland VH, Konfortion J, Jack RH et al (2016) Resection rate, hospital procedure volume and survival in pancreatic cancer patients in England: population-based study, 2005\u20132009. Eur J Surg Oncol 42:190\u2013196","journal-title":"Eur J Surg Oncol"},{"key":"9849_CR4","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.surg.2015.12.024","volume":"159","author":"AP Stark","year":"2016","unstructured":"Stark AP, Sacks GD, Rochefort MM et al (2016) Long-term survival in patients with pancreatic ductal adenocarcinoma. Surgery 159:1520\u20131527","journal-title":"Surgery"},{"key":"9849_CR5","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s11605-007-0243-7","volume":"11","author":"MG House","year":"2007","unstructured":"House MG, Gonen M, Jarnagin WR et al (2007) Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg 11:1549\u20131555","journal-title":"J Gastrointest Surg"},{"key":"9849_CR6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1091-255X(00)80105-5","volume":"4","author":"TA Sohn","year":"2000","unstructured":"Sohn TA, Yeo CJ, Cameron JL et al (2000) Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4:567\u2013579","journal-title":"J Gastrointest Surg"},{"key":"9849_CR7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00000658-200301000-00011","volume":"237","author":"JE Lim","year":"2003","unstructured":"Lim JE, Chien MW, Earle CC (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237:74\u201385","journal-title":"Ann Surg"},{"key":"9849_CR8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00268-002-6659-z","volume":"27","author":"A Richter","year":"2003","unstructured":"Richter A, Niedergethmann M, Sturm JW et al (2003) Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 27:324\u2013329","journal-title":"World J Surg"},{"key":"9849_CR9","doi-asserted-by":"crossref","first-page":"e1000267","DOI":"10.1371\/journal.pmed.1000267","volume":"7","author":"S Gillen","year":"2010","unstructured":"Gillen S, Schuster T, Meyer Zum Buschenfelde C et al (2010) Preoperative\/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med 7:e1000267","journal-title":"PLoS Med"},{"key":"9849_CR10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00280-013-2368-6","volume":"73","author":"K Sudo","year":"2014","unstructured":"Sudo K, Ishihara T, Hirata N et al (2014) Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer. Cancer Chemother Pharmacol 73:389\u2013396","journal-title":"Cancer Chemother Pharmacol"},{"key":"9849_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1634\/theoncologist.2014-0394","volume":"20","author":"J Tabernero","year":"2015","unstructured":"Tabernero J, Chiorean EG, Infante JR et al (2015) Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer. Oncologist 20:143\u2013150","journal-title":"Oncologist"},{"key":"9849_CR12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejca.2012.07.017","volume":"49","author":"JK Bjerregaard","year":"2013","unstructured":"Bjerregaard JK, Mortensen MB, Schonnemann KR, Pfeiffer P (2013) Characteristics, therapy and outcome in an unselected and prospectively registered cohort of pancreatic cancer patients. Eur J Cancer 49:98\u2013105","journal-title":"Eur J Cancer"},{"key":"9849_CR13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"88","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi B, Arvieux C, Glehen O et al (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88:358\u2013363","journal-title":"Cancer"},{"key":"9849_CR14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MPA.0b013e31825abf8c","volume":"42","author":"I Thomassen","year":"2013","unstructured":"Thomassen I, Lemmens VE, Nienhuijs SW et al (2013) Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study. Pancreas 42:72\u201375","journal-title":"Pancreas"},{"key":"9849_CR15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<254::AID-SSU10>3.0.CO;2-U","volume":"14","author":"PH Sugarbaker","year":"1998","unstructured":"Sugarbaker PH (1998) Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 14:254\u2013261","journal-title":"Semin Surg Oncol"},{"key":"9849_CR16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","volume":"21","author":"W Solass","year":"2014","unstructured":"Solass W, Kerb R, Murdter T et al (2014) Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol 21:553\u2013559","journal-title":"Ann Surg Oncol"},{"key":"9849_CR17","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1245\/s10434-013-3039-x","volume":"20","author":"W Solass","year":"2013","unstructured":"Solass W, Giger-Pabst U, Zieren J, Reymond MA (2013) Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects. Ann Surg Oncol 20:3504\u20133511","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"9849_CR18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1515\/pp-2016-0019","volume":"1","author":"M Graversen","year":"2016","unstructured":"Graversen M, Pedersen PB, Mortensen MB (2016) Environmental safety during the administration of pressurized intraperitoneal aerosol chemotherapy. Pleura and Peritoneum 1(4):203\u2013208","journal-title":"Pleura and Peritoneum"},{"key":"9849_CR19","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1245\/s10434-012-2840-2","volume":"20","author":"A Blanco","year":"2013","unstructured":"Blanco A, Giger-Pabst U, Solass W et al (2013) Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC). Ann Surg Oncol 20:2311\u20132316","journal-title":"Ann Surg Oncol"},{"key":"9849_CR20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ygyno.2013.11.022","volume":"132","author":"CB Tempfer","year":"2014","unstructured":"Tempfer CB, Celik I, Solass W et al (2014) Activity of pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience. Gynecol Oncol 132:307\u2013311","journal-title":"Gynecol Oncol"},{"key":"9849_CR21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ygyno.2015.02.009","volume":"137","author":"CB Tempfer","year":"2015","unstructured":"Tempfer CB, Winnekendonk G, Solass W et al (2015) Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study. Gynecol Oncol 137:223\u2013228","journal-title":"Gynecol Oncol"},{"key":"9849_CR22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11605-015-2995-9","volume":"20","author":"G Nadiradze","year":"2016","unstructured":"Nadiradze G, Giger-Pabst U, Zieren J et al (2016) Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with low-dose cisplatin and doxorubicin in gastric peritoneal metastasis. J Gastrointest Surg 20:367\u2013373","journal-title":"J Gastrointest Surg"},{"key":"9849_CR23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/codi.13130","volume":"18","author":"C Demtroder","year":"2016","unstructured":"Demtroder C, Solass W, Zieren J et al (2016) Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis. Colorectal Dis 18:364\u2013371","journal-title":"Colorectal Dis"},{"key":"9849_CR24","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","volume":"26","author":"W Solass","year":"2012","unstructured":"Solass W, Hetzel A, Nadiradze G et al (2012) Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc 26:1849\u20131855","journal-title":"Surg Endosc"},{"key":"9849_CR25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213","journal-title":"Ann Surg"},{"issue":"2","key":"9849_CR26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1515\/pp-2016-0011","volume":"1","author":"W Solass","year":"2016","unstructured":"Solass W, Detlefsen S, Carr N et al (2016) Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS). Pleura and Peritoneum 1(2):99\u2013107","journal-title":"Pleura and Peritoneum"},{"key":"9849_CR27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247","journal-title":"Eur J Cancer"},{"key":"9849_CR28","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s10637-016-0369-0","volume":"34","author":"N Takahara","year":"2016","unstructured":"Takahara N, Isayama H, Nakai Y et al (2016) Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites. Invest New Drugs 34:636\u2013642","journal-title":"Invest New Drugs"},{"key":"9849_CR29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/ejso.2001.1157","volume":"27","author":"M Oman","year":"2001","unstructured":"Oman M, Blind PJ, Naredi P et al (2001) Treatment of non-resectable pancreatic cancer with intraperitoneal 5-FU and leucovorin IV. Eur J Surg Oncol 27:477\u2013481","journal-title":"Eur J Surg Oncol"},{"key":"9849_CR30","doi-asserted-by":"crossref","first-page":"F433","DOI":"10.1152\/ajprenal.00313.2004","volume":"288","author":"MF Flessner","year":"2005","unstructured":"Flessner MF (2005) The transport barrier in intraperitoneal therapy. Am J Physiol Renal Physiol 288:F433\u2013F442","journal-title":"Am J Physiol Renal Physiol"},{"key":"9849_CR31","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/00001813-199607000-00016","volume":"7","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Stuart OA, Chang D, Sugarbaker PH (1996) Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. Anticancer Drugs 7:596\u2013603","journal-title":"Anticancer Drugs"},{"key":"9849_CR32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00464-011-1964-y","volume":"26","author":"W Solass","year":"2012","unstructured":"Solass W, Herbette A, Schwarz T et al (2012) Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept. Surg Endosc 26:847\u2013852","journal-title":"Surg Endosc"},{"key":"9849_CR33","doi-asserted-by":"crossref","DOI":"10.1515\/9783110366617","volume-title":"PIPAC pressurized intraperitoneal aerosol chemotherapy\u2014Cancer under pressure","author":"MA Reymond","year":"2014","unstructured":"Reymond MA (2014) PIPAC pressurized intraperitoneal aerosol chemotherapy\u2014Cancer under pressure. Walter de Gruyter, Berlin"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-017-9849-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-017-9849-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-017-9849-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T17:13:46Z","timestamp":1659028426000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-017-9849-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,17]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["9849"],"URL":"https:\/\/doi.org\/10.1007\/s10585-017-9849-7","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,17]]}}}